The first venture fund dedicated to diabetes technology

Tapping a unique market opportunity

We’re bringing together a unique constellation of partners to invest globally in exceptional diabetes technology startups.

Learn more

Serpentine Ventures, the investment arm of the Swiss Ventures Group, enables growth by facilitating investments in passionate people and bold ideas.

The DCB, a global center for technology innovation in diabetes, transforms diagnosis and treatment for people living with diabetes by addressing unmet needs.

Cookies

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

Cookies

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

Your cookie preferences have been saved.